SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

36.55

70.23

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

Hinduja Global Solutions reports consolidated net profit of Rs 42.58 crore in the December 2025 quarter

Feb 11,2026

Net profit of Hinduja Global Solutions reported to Rs 42.58 crore in the quarter ended December 2025 as against net loss of Rs 2.64 crore during the previous quarter ended December 2024. Sales rose 1.07% to Rs 1075.42 crore in the quarter ended December 2025 as against Rs 1064.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1075.42	1064.05	1
OPM %	1.58	5.97	-
PBDT	86.79	178.79	-51
PBT	-36.54	41.26	PL
NP	42.58	-2.64	LP

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)